Aldosteronism Clinical Trials

2 recruiting

Frequently Asked Questions

Common questions about Aldosteronism clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 21 trials

Recruiting

Steroids-Based Screening for Primary Aldosteronism

HypertensionPrimary Aldosteronism
Qifu Li406 enrolled1 locationNCT06941116
Recruiting
Not Applicable

Superselective Adrenal Arterial Embolization Versus Oral Spironolactone for Treatment of Idiopathic Hyperaldosteronism

Idiopathic HyperaldosteronismHyperaldosteronism
Chinese Academy of Medical Sciences, Fuwai Hospital172 enrolled3 locationsNCT07328230
Recruiting
Phase 2

Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism

HypercortisolismHyperaldosteronismCushing s Syndrome
National Cancer Institute (NCI)80 enrolled1 locationNCT06246357
Recruiting

Multi-omics Studies of Primary Aldosteronism

Primary Aldosteronism
Peking University First Hospital400 enrolled1 locationNCT07111351
Recruiting

Overnight Dexamethasone in Primary Aldosteronism Screening

HypertensionPrimary Aldosteronism
Medical University of Gdansk240 enrolled1 locationNCT06740838
Recruiting

Efficacy of Spironolactone Combined With Antihypertensive Drugs in Patients With Primary Aldosteronism

HypertensionPrimary Aldosteronism
Third Military Medical University350 enrolled1 locationNCT07137364
Recruiting
Not Applicable

PETAL Trial: Impact of Gallium-68 Pentixafor PET-CT on Surgical Outcomes in Primary Aldosteronism

Primary AldosteronismSecondary HypertensionAldosterone-Producing Adenoma+2 more
Seoul National University Hospital90 enrolled2 locationsNCT07027254
Recruiting

Diagnosing Variable Primary Aldosteronism.

Primary AldosteronismHigh Blood Pressure
Queen Mary University of London100 enrolled1 locationNCT05765786
Recruiting

Tissue Sodium Quantification in Patients With Primary Aldosteronism: See Sodium to Treat

HypertensionPrimary AldosteronismHypokalemia
Jens Titze80 enrolled4 locationsNCT06569589
Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Heart FailurePainInsomnia+22 more
Duke University5,000 enrolled51 locationsNCT04278404
Recruiting
Phase 4

Cardiovascular Manifestations of MR Activation in Primary Aldosteronism: Pilot Clinical Study

HypertensionPrimary Aldosteronism
Brigham and Women's Hospital40 enrolled1 locationNCT05030545
Recruiting
Phase 4

Statin Combined with Amlodipine Treats Primary Aldosteronism

HypertensionPrimary AldosteronismStatin+1 more
Third Military Medical University180 enrolled1 locationNCT06523465
Recruiting
Not Applicable

Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism

Primary AldosteronismHypercortisolismAldosterone-Producing Adenoma
Haukeland University Hospital60 enrolled1 locationNCT05368090
Recruiting
Phase 4

Finerenone for Patients With Primary Aldosteronism (FAIRY)

Primary Aldosteronism
Qifu Li306 enrolled1 locationNCT06457074
Recruiting
Not Applicable

Effects of Adrenal Artery Ablation and Spironolactone in Patients With Primary Aldosteronism

HypertensionPrimary Aldosteronism
Third Military Medical University60 enrolled1 locationNCT04409431
Recruiting

A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China

Liver CancerPancreatic CancerGastric Cancer+8 more
Zhujiang Hospital12,000 enrolled50 locationsNCT05638269
Recruiting
Not Applicable

Preoperative Supine Time for Adrenal Venous Sampling

Primary Aldosteronism
Second Affiliated Hospital, School of Medicine, Zhejiang University120 enrolled1 locationNCT05658705
Recruiting

Water and Electrolytes Content in HYpertension (WHYSKI) in the SKIn

HypertensionEssential HypertensionAldosterone-Producing Adenoma+5 more
University Hospital Padova35 enrolled1 locationNCT06090617
Recruiting

Comparison of Catecholamine Concentrations in Venous Blood During Selective Adrenal Artery Embolization

Primary AldosteronismSecondary HypertensionResistant Hypertension+1 more
First Affiliated Hospital of Chengdu Medical College196 enrolled1 locationNCT06228677
Recruiting

National Registry of Rare Kidney Diseases

Denys-Drash SyndromeTuberous SclerosisAutosomal Recessive Polycystic Kidney Disease+81 more
UK Kidney Association35,000 enrolled1 locationNCT06065852